Business
CSL (ASX:CSL) share price wobbles on COVID vaccine news – The Motley Fool Australia
The CSL Limited (ASX: CSL) share price is on watch after the UK found “possible links” between the AstraZeneca vaccine and blood clots.
The CSL Limited (ASX: CSL) share price is a little wobbly this morning after negative vaccine news overnight from the United Kingdom.
The pharmaceutical giant, which produces and supplies the AstraZeneca PLC (LSE: AZ)COVID-19 vaccine in Australia, is trading close to its opening price after news that the UK medical regulator has found a “possible link” between the vaccine and blood clotting in younger adults. The regulator noted that blood clotting was considered a rare side-effect of the vaccine.
…
-
Noosa News23 hours agoUnderstanding the conflict conundrum – Proctor
-
Business23 hours ago9 ASX shares including Nuix and PolyNovo dumped from ASX 200
-
Noosa News24 hours agoThree Bartender-Approved Peanut Butter Whisky Cocktails
-
Business24 hours agoGood rains mean this ASX 200 agricultural stock is tipped to deliver double-digit returns